SCIENTIFIC FOCUS CELL DIFFERENTIATION, REGENERATION AND NEOPLASIA

SPEAKER
Univ.-Prof. Dr. med. Frank Tüttelmann
Clinic for Medical Genetics 

Funded projects

  • Kr4/003/25 - Die Funktionen epithelialer Polarität bei der Pathogenese des Kolonkarzinoms
    Principal investigator: Michael Krahn
    Funding period: 01/2025 - 12/2027
  • Hai4/007/25 - Die Bedeutung Ferroptose-induzierter extrazellulärer Vesikel beim diffusen großzelligen B-Zell-Lymphom
    Principal investigators: Stephan Hailfinger, Kerstin Menck
    Funding period: 01/2025 - 12/2027
  • Ros4/003/23 - Transcription factor PU.1-controlled stem cell genes in acute myeloid leukemia
    Principal investigator: Frank Rosenbauer
    Funding period: 01/2023 - 12/2025
  • Rö4/006/23 - CAR T cells with antigen-induced secretion of a soluble IGF1R signaling inhibitor for combined molecular and immune targeting of Ewing sarcoma
    Principal investigators: Claudia Rössig, Sebastian Bäumer
    Funding period: 01/2023 - 12/2025
  • Tüt4/011/23 - Contribution of the piRNA pathway to spermatogenic failure and male infertility
    Principal investigator: Frank Tüttelmann
    Funding period: 01/2023 - 12/2025
  • Weh4/022/23 - Impact of osteocyte-cancer cell crosstalk on bone homeostasis in multiple myeloma
    Principal investigator: Corinna Wehmeyer
    Funding period: 01/2023 - 12/2025
  • Kek4/016/22 - Identifying mechanisms of microglia- tumor cell interactions in the induction of chemotherapy resistance in retinoblastoma
    Principal investigator: Kornelius Kerl
    Funding period: 01/2022 - 12/2024

  • completed IZKF Projects - Scientific Focus Cell differentiation, Regeneration and Neoplasia

    • Kek4/016/22 - Identifying mechanisms of microglia- tumor cell interactions in the induction of chemotherapy resistance in retinoblastoma
      Principal investigator: Kornelius Kerl
      Funding period: 01/2022 - 12/2024
    • Lud4/013/21 - Exploiting synergistic anti-cancer efficacy by combining oncolytic viruses and CAR Tcells to target lung cancer
      Principal Investigator: Stephan Ludwig
      Funding period: 01/2021 - 06/2024
    • Kr4/031/21 - Characterization of new substrates of the tumor suppressor LKB1 in thepathogenesis of cancerEbl4/009/21 - Pinpointing distinct rhodocytin suprastructures and novel CLEC-2 targeting toxins to curb podoplanin-mediated platelet assistance of hematogenous metastasis
      Principal Investigator: Johannes Eble
      Funding period: 01/2021 - 12/2023
    • Mik4/015/21 - Investigation of the role of the Armadillo repeat-containing X-linked Protein (ARMCX)family in normal hematopoiesis and acute myeloid leukemia
      Principal Investigator: Jan-Henrik Mikesch
      Funding period: 01/2021 - 12/2023